These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20857284)

  • 21. Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas.
    Dhermain F; Saliou G; Parker F; Page P; Hoang-Xuan K; Lacroix C; Tournay E; Bourhis J; Ducreux D
    J Neurooncol; 2010 Mar; 97(1):81-8. PubMed ID: 19727561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading.
    Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH
    PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
    Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
    Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
    Bell LC; Stokes AM; Quarles CC
    J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
    Smitha KA; Gupta AK; Jayasree RS
    Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
    Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
    AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
    Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
    J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.
    Alcaide-Leon P; Pareto D; Martinez-Saez E; Auger C; Bharatha A; Rovira A
    AJNR Am J Neuroradiol; 2015 May; 36(5):871-6. PubMed ID: 25634715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
    Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
    J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.
    Di Stefano AL; Bergsland N; Berzero G; Farina L; Rognone E; Gastaldi M; Aquino D; Frati A; Tomasello F; Ceroni M; Marchioni E; Bastianello S
    Biomed Res Int; 2014; 2014():154350. PubMed ID: 24800207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
    Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
    J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.
    Hu LS; Baxter LC; Pinnaduwage DS; Paine TL; Karis JP; Feuerstein BG; Schmainda KM; Dueck AC; Debbins J; Smith KA; Nakaji P; Eschbacher JM; Coons SW; Heiserman JE
    AJNR Am J Neuroradiol; 2010 Jan; 31(1):40-8. PubMed ID: 19749223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.